glp-1 diabetes Glucagon-like peptide-1 GLP-1: Actions on Beta-cell Mass

With the right plan, medical support, and mindset, long-term weight loss results can be maintained.

Mechanisms underlying long-term sustained weight loss and glycemic normalization after obesity surgery include changes in gut hormone levels, including glucagon-like peptide 1 (GLP-1) and peptide YY (PYY)

Tirzepatide, a novel GLP-1/GIP dual receptor agonist, shows significant advantages in glycemic management and weight control

GLP-1 medications are associated with an increased incidence of hypotensive events in patients taking two or more hypertension treatments, according to a large retrospective observational study.

The global GLP-1 market is on a significant growth trajectory, anticipated to rise from an estimated $44.5 million in 2023 to $95.4 million by 2031,...